Complete remission of lung metastasis following adoptive immunotherapy using activated autologous γδ T-cells in a patient with renal cell carcinoma

Anticancer Research

Volumn 30, Issue 2, 2010, Pages 575-579

  Kobayashi, Hirohito ^a   Tanaka, Yoshimasa ^b   Shimmura, Hiroaki ^c   Minato, Nagahiro ^b   Tanabe, Kazunari ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Tokiwakai Iwald Hinyoukika Hospital   (Japan)

Author keywords

Adoptive immunotherapy; Gamma delta T cells; Renal cell carcinoma

Indexed keywords

ALPHA INTERFERON; CREATININE; INTERLEUKIN 2; ZOLEDRONIC ACID;

ADOPTIVE IMMUNOTHERAPY; ADULT; ARTICLE; CANCER REGRESSION; CASE REPORT; CELL THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; EOSINOPENIA; FEVER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOALBUMINEMIA; HYPOCALCEMIA; KIDNEY CARCINOMA; LOW DRUG DOSE; LUNG METASTASIS; MALE; NEPHRECTOMY; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; BONE DENSITY CONSERVATION AGENTS; CARCINOMA, RENAL CELL; DIPHOSPHONATES; DRUG THERAPY, COMBINATION; HUMANS; IMIDAZOLES; IMMUNOTHERAPY, ADOPTIVE; INTERFERON-GAMMA; INTERLEUKIN-2; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; REMISSION INDUCTION; T-LYMPHOCYTES; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 77950532926     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Porcelli S, Brenner MB and Band H: Biology of human γδ T-cell receptor. Immunol Rev 120: 137-183, 1991.
2. Kobayashi H, Tanaka Y, Yagi J, Osaka Y, Nakazawa H, Uchiyama T, Minato N and Toma H: Safety profile and antitumor effects of adoptive immunotherapy using γδ T-cells against advanced renal cell carcinoma: a pilot study. Cancer Immunol Immunother 56: 469-476, 2007.
3. Wilhelm M, Kunzmann V, Eckstein S, Reimer P, Weissinger F, Ruediger T and Tony HP: γδ T-cells for immune therapy of patients with lymphoid malignancies. Blood 102: 200-206, 2003.
4. Dieli F, Vermijlen D, Fulfaro F, Caccamo N, Meraviglia S, Cicero G, Roberts A, Buccheri S, D'Asaro M, Gebbia N, Salerno A, Eberl M and Hayday AC: Targeting human γδ T-cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res 67: 7450-7457, 2007.
5. Tanaka Y, Kobayashi H, Terasaki T, Toma H, Aruga A, Uchiyama T, Mizutani K, Mikami B, Morita CT and Minato N: Synthesis of pyrophosphate-containing compounds that stimulate Vγ2Vδ2 T-cells: application to cancer immunotherapy. Med Chem 3(1): 85-99, 2007.
6. Kato Y, Tanaka Y, Miyagawa F, Yamashita S and Minato N: Targeting of tumor cells for human γδ T-cells by nonpeptide antigens. J Immunol 167: 5092-5098, 2001.
7. Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R and Bukowski RM, for the TARGET Study Group: Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356: 123-134, 2007.
8. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM and Figlin RA: Sunitinib versus interferon alpha in metastatic renal-cell carcinoma. N Engl J Med 356: 115-124, 2007.
9. Ikemoto S, Yoshida N, Narita K, Wada S, Kishimoto T, Sugimura K and Nakatani T: Role of tumor-associated macrophages in renal cell carcinoma. Oncol Rep 10(6): 1843-1849, 2003.
10. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M and O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147(11): 3815-3822, 1991.
11. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Osaka Y, Futatsuyama K, Toma H and Tanabe K: Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response. Cancer Sci 97: 780-786, 2006.
12. Kobayashi H, Tanaka Y, Yagi J, Toma H and Uchiyama T: γδ T-cells provide innate immunity against renal cell carcinoma. Cancer Immunol Immunother 50(3): 115-124, 2001.